A colony of Bacillus subtilis (right) inhibits growth of human pathogen S. epidermus.
Researchers at the University of California, San Diego (UCSD)Â have revealed new details about how cannibalistic bacteria identify peers suitable for consumption. The work, which employed imaging mass spectrometry, is a first step toward a broader effort to map all signaling molecules between organisms.
These are the molecules that control biology, said Pieter C. Dorrestein, PhD, associate professor at UC San Diegos Skaggs School of Pharmacy and Pharmaceutical Sciences and corresponding author of a paper published this week in the online edition of the Proceedings of the National Academy of Sciences.
Bacterial cannibalism occurs when a subpopulation of a microbial colony eats another subpopulation, harvesting the latters nutrients to sustain growth in times when external food sources are limited. The phenomenon is well-known, but not well-characterized. For example, researchers have not known exactly how microbes identify, select and kill their genetically identical siblings.
Dorrestein, with colleagues at UC San Diego and in Iowa and Texas, studied Bacillus subtilis, a common species with a complex life cycle that thrives in diverse living conditions, from soil to contaminated wounds to the intestinal tract. Using imaging mass spectrometry, the researchers generated spatial distributions or chemical maps of molecules within the microbe, focusing in particular on two metabolites called sporulation delaying protein (SDP) and sporulation killing factor (SKF), which the scientists correctly hypothesized were directly involved in the cannibalistic process.
These are the first fully characterized molecules that enable B. subtilis to digest or differentiate genetically identical cells, said Dorrestein. Our work also shows that the molecules the bacteria uses to differentiate themselves are akin to those of a multicellular organism, even though the microbes are genetically identical. Most people do not think of a microbial colony as a differentially organized multicellular organism.
Since SDP and SKF were involved in killing bacteria, the scientists also explored whether the molecules might be effective weapons against human pathogens. Their findings were mixed. SKF had no effect on targeted pathogens like Pseudomonas aeruginosa or Klebsiella pneumonia, but SDP displayed potent inhibitory activity against two variants of Staphylococcus aureus and other pathogens. Dorrestein said SDP itself has limited potential as an antibacterial agent, but it could serve as an antibiotic lead compound where the active portion can be modified to meet the requirements of a therapeutic agent. It further shows that imaging mass spectrometry can be used to discover biologically active molecules.
He said additional antibacterial molecules are likely to be found in other cannibalistic species, but they remain to be identified and described.
Co-authors with Dorrestein are Wei-Ting Liu, Jane Y. Yang and David Gonzalez of the Department of Chemistry and Biochemistry at UCSD; Yu-Liang Yang and Yuquan Xu of UCSDs Skaggs School of Pharmacy and Pharmaceutical Sciences; Anne Lamsa of the Division of Biological Sciences at UCSD; Nina M. Haste of the Center for Marine Biotechnology and Biomedicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences; Julio Ng of the Department of Computer Science at UCSD; Craig D. Ellermeier of the Department of Microbiology, University of Iowa; Paul D. Straight of the Department of Biochemistry and Biophysics at Texas A&M University; Pavel A. Pevzner of UCSDs Department of Computer Science and the National Center for Research Resources Center for Computational Mass Spectrometry; Joe Pogliano of UCSDs Division of Biological Sciences; Victor Nizet of the Skaggs School of Pharmacy and Pharmaceutical Science, Center for Marine Biotechnology and Biomedicine and Department of Pediatrics, UC San Diego; and Kit Pogliano, UCSD Division of Biological Sciences.
Â
Undermining Public Health: Nearly 1300 Cut From CDC With More to Come
February 14th 2025The Trump administration’s decision to terminate nearly 1,300 CDC employees weakens America’s public health defenses, jeopardizes critical research, and endangers the nation’s preparedness for future health crises.
Infection Intel: GermZapp Is the Innovative Hand Hygiene System IPC Needs
February 14th 2025GermZAPP is an affordable hand hygiene system designed to educate, monitor, and encourage adherence in schools, nursing homes, and health care settings, effectively addressing gaps in infection control.
Strengthening Infection Prevention: APIC Urges Support From HHS Secretary Kennedy
February 13th 2025APIC congratulates Secretary Robert F. Kennedy, Jr on his appointment and urges support for infection prevention priorities, including NHSN funding, workforce development, nursing home IPC improvements, medical device cleaning standards, and global health collaboration.
Universities and States Sue NIH Over Funding Cuts, Federal Judge Temporarily Halts Policy
February 13th 2025Twelve universities and 3 education groups filed a lawsuit against the NIH and HHS, challenging a 15% cap on research grant funding. A federal judge issued a temporary restraining order, halting the cuts while litigation proceeds. A hearing is set for February 21, 2025, and states and institutions are pushing for permanent relief.